Abbott Laboratories (SWX:ABT)
93.50
0.00 (0.00%)
Sep 30, 2024, 9:05 AM CET
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $11.14B USD in the quarter ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to $43.11B, up 5.85% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$43.11B
Revenue Growth
+5.85%
P/S Ratio
5.03
Revenue / Employee
$378.15K
Employees
114,000
Market Cap
172.47B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 43.89B |
Lonza Group AG | 6.57B |
Alcon | 8.77B |
Galderma Group AG | 4.02B |
Sandoz Group AG | 9.41B |
Straumann Holding AG | 2.50B |
Sonova Holding AG | 3.87B |
Abbott Laboratories News
- 3 days ago - Looking Into Abbott Laboratories's Recent Short Interest - Benzinga
- 3 days ago - Analysts defend Abbott Labs' stock after Thursday's 'too punitive' sell-off - CNBC
- 3 days ago - tech giants stumble as Tesla accelerates: Unpacking today's mixed market signals - Forexlive
- 3 days ago - These Analysts Revise Their Forecasts On Abbott Following Q2 Results - Benzinga
- 3 days ago - These Analysts Revise Their Forecasts On Abbott Following Q2 Results - Benzinga
- 3 days ago - Abbott Laboratories: What's Behind The Q2 Earnings Slump? - Seeking Alpha
- 3 days ago - Microsoft To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
- 4 days ago - Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction' - CNBC